DORIA, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 248
EU - Europa 165
AS - Asia 103
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 520
Nazione #
US - Stati Uniti d'America 245
IE - Irlanda 85
CN - Cina 75
FI - Finlandia 30
IT - Italia 28
DE - Germania 17
SG - Singapore 15
JP - Giappone 7
CA - Canada 3
IN - India 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BO - Bolivia 1
EG - Egitto 1
EU - Europa 1
GB - Regno Unito 1
MA - Marocco 1
NL - Olanda 1
OM - Oman 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 520
Città #
Dublin 85
Chandler 69
Helsinki 30
Boardman 16
Nanjing 15
Ashburn 14
Beijing 14
Pavia 14
Princeton 13
Lawrence 12
Medford 10
Shanghai 10
Nanchang 7
Singapore 7
Tokyo 7
Chicago 6
Shenyang 6
Wilmington 6
Changsha 5
Hebei 5
Los Angeles 5
Reggio Emilia 4
Jiaxing 3
Norwalk 3
Canyon Country 2
Dallas 2
Falkenstein 2
Frankfurt am Main 2
Hangzhou 2
Jacksonville 2
Montreal 2
Napoli 2
New York 2
Rome 2
San Francisco 2
Asyut 1
Calgary 1
Denver 1
Des Moines 1
Ergolding 1
Fairfield 1
Guangzhou 1
Jinan 1
Munich 1
Muscat 1
Naples 1
Noicattaro 1
Piscataway 1
Pune 1
Riyadh 1
Santa Clara 1
Seattle 1
Sucre 1
Tianjin 1
Woodbridge 1
Totale 408
Nome #
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 68
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort 50
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 49
“Disease knowledge index” and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 46
Idiopathic inflammatory myopathies: Narrative review of unmet needs in clinical practice guidelines 45
Undifferentiated connective tissue disease: State of the art on clinical practice guidelines 42
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 40
Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners 38
The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET 31
Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database 29
Health-related quality of life in patients with mixed connective tissue disease: a comparison with matched systemic sclerosis patients 27
Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up 26
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 25
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region 11
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model 9
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs 4
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 4
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 3
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathway 1
Totale 548
Categoria #
all - tutte 3.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.569


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 0 0 0 1 5 8 0
2020/202120 0 0 0 0 0 0 0 3 14 3 0 0
2021/202255 1 0 0 0 2 2 2 1 4 0 7 36
2022/2023237 31 18 6 8 13 26 2 16 106 0 5 6
2023/202498 18 10 3 8 5 14 2 8 5 10 3 12
2024/202568 14 19 3 5 6 21 0 0 0 0 0 0
Totale 548